These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 30887761)
1. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study. Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761 [TBL] [Abstract][Full Text] [Related]
2. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus. Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927 [TBL] [Abstract][Full Text] [Related]
3. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study. Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395 [TBL] [Abstract][Full Text] [Related]
4. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? Kwon JS; Abrams J; Sugimoto A; Carey MS Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450 [TBL] [Abstract][Full Text] [Related]
5. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230 [TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma. Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723 [TBL] [Abstract][Full Text] [Related]
7. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases. Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038 [TBL] [Abstract][Full Text] [Related]
8. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy. Chang-Halpenny CN; Natarajan S; Hwang-Graziano J Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679 [TBL] [Abstract][Full Text] [Related]
9. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers. Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917 [TBL] [Abstract][Full Text] [Related]
10. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma. Kim A; Schreiber D; Rineer J; Choi K; Rotman M Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e639-44. PubMed ID: 21507584 [TBL] [Abstract][Full Text] [Related]
13. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma. Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840 [TBL] [Abstract][Full Text] [Related]
14. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Murphy KT; Rotmensch J; Yamada SD; Mundt AJ Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related]
17. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Carcangiu ML; Chambers JT Int J Gynecol Pathol; 1995 Jan; 14(1):30-8. PubMed ID: 7883423 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878 [TBL] [Abstract][Full Text] [Related]
19. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202 [TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]